BriaCell Therapeutics Corp. Warrant Share Price Today, Forecast Target, Chat & Where To Buy [BCTXW]

Home > Share Prices > BriaCell Therapeutics Corp. Warrant share price (BCTXW)

Today's BriaCell Therapeutics Corp. Warrant share price is 0.06 (as of 12:11 22-Oct-2025) which is a change of 0.01 or -8.33% from the last closing price of 0.06 with 7,460 shares traded giving BriaCell Therapeutics Corp. Warrant a market capitalisation of 31,536,586. The most recent daily high has been 0.06 and daily low 0.06. The BriaCell Therapeutics Corp. Warrant share price 52 week high has been 0.7 and the 52 week low 0.01. Based on the most recent BriaCell Therapeutics Corp. Warrant share price opening of 0.06, the current BriaCell Therapeutics Corp. Warrant EPS (earnings per share) are n/a and the PE (price earnings ratio) is n/a.

Featured Brokers For Buying BriaCell Therapeutics Corp. Warrant Shares

It currently costs 0.06 to buy one share in BriaCell Therapeutics Corp. Warrant (as of 12:11 22-Oct-2025) which is a change of 0.01 or -8.33% from the last closing price of 0.06. To buy shares in BriaCell Therapeutics Corp. Warrant you will need a stock trading platform like Interactive Brokers, IG or AJ Bell.

You can buy these shares in either a general investment account, stocks & shares ISA or SIPP for your pension with one of the brokers below.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is BriaCell Therapeutics Corp. Warrant A Good Investment?

The below BriaCell Therapeutics Corp. Warrant share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.

Tell us what you think:

Scroll to Top